Deep Reinforcement Learning for Early Diagnosis of Lung Cancer
Yifan Wang, Qining Zhang, Lei Ying, Chuan Zhou
Abstract
Lung cancer remains the leading cause of cancer-related death worldwide, and early diagnosis of lung cancer is critical for improving the survival rate of patients. Performing annual low-dose computed tomography (LDCT) screening among high-risk populations is the primary approach for early diagnosis. However, after each screening, whether to continue monitoring (with follow-up screenings) or to order a biopsy for diagnosis remains a challenging decision to make. Continuing with follow-up screenings may lead to delayed diagnosis but ordering a biopsy without sufficient evidence incurs unnecessary risk and cost. In this paper, we tackle the problem by an optimal stopping approach. Our proposed algorithm, called EarlyStop-RL, utilizes the structure of the Snell envelope for optimal stopping, and model-free deep reinforcement learning for making diagnosis decisions. Through evaluating our algorithm on a commonly used clinical trial dataset (the National Lung Screening Trial), we demonstrate that EarlyStop-RL has the potential to greatly enhance risk assessment and early diagnosis of lung cancer, surpassing the performance of two widely adopted clinical models, namely the Lung-RADS and the Brock model.
BibTeX
@article{Wang_Zhang_Ying_Zhou_2024, title={Deep Reinforcement Learning for Early Diagnosis of Lung Cancer}, volume={38}, url={https://ojs.aaai.org/index.php/AAAI/article/view/30248}, DOI={10.1609/aaai.v38i20.30248}, abstractNote={Lung cancer remains the leading cause of cancer-related death worldwide, and early diagnosis of lung cancer is critical for improving the survival rate of patients. Performing annual low-dose computed tomography (LDCT) screening among high-risk populations is the primary approach for early diagnosis. However, after each screening, whether to continue monitoring (with follow-up screenings) or to order a biopsy for diagnosis remains a challenging decision to make. Continuing with follow-up screenings may lead to delayed diagnosis but ordering a biopsy without sufficient evidence incurs unnecessary risk and cost. In this paper, we tackle the problem by an optimal stopping approach. Our proposed algorithm, called EarlyStop-RL, utilizes the structure of the Snell envelope for optimal stopping, and model-free deep reinforcement learning for making diagnosis decisions. Through evaluating our algorithm on a commonly used clinical trial dataset (the National Lung Screening Trial), we demonstrate that EarlyStop-RL has the potential to greatly enhance risk assessment and early diagnosis of lung cancer, surpassing the performance of two widely adopted clinical models, namely the Lung-RADS and the Brock model.}, number={20}, journal={Proceedings of the AAAI Conference on Artificial Intelligence}, author={Wang, Yifan and Zhang, Qining and Ying, Lei and Zhou, Chuan}, year={2024}, month={Mar.}, pages={22410-22419} }